[HTML][HTML] Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection
MG Savelieff, EL Feldman, AM Stino - Neurobiology of disease, 2022 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic is responsible for 267 million
infections and over 5 million deaths globally. COVID-19 is caused by severe acute …
infections and over 5 million deaths globally. COVID-19 is caused by severe acute …
[HTML][HTML] Effects of COVID-19 on the nervous system
Neurological complications have emerged as a significant cause of morbidity and mortality
in the ongoing COVID-19 pandemic. Beside respiratory insufficiency, many hospitalized …
in the ongoing COVID-19 pandemic. Beside respiratory insufficiency, many hospitalized …
[HTML][HTML] Elucidating the neuropathologic mechanisms of SARS-CoV-2 infection
M Pacheco-Herrero, LO Soto-Rojas… - Frontiers in …, 2021 - frontiersin.org
The current pandemic caused by the new severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has become a public health emergency. To date, March 1, 2021, coronavirus …
(SARS-CoV-2) has become a public health emergency. To date, March 1, 2021, coronavirus …
[HTML][HTML] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives
G Vargas, LHM Geraldo, NG Salomão, MV Paes… - Brain, behavior, & …, 2020 - Elsevier
In December 2019, a pneumonia outbreak was reported in Wuhan, Hubei province, China.
Since then, the World Health Organization declared a public health emergency of …
Since then, the World Health Organization declared a public health emergency of …
[HTML][HTML] Neuroinflammation and Its Impact on the Pathogenesis of COVID-19
MM Almutairi, F Sivandzade, TH Albekairi… - Frontiers in …, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical manifestations of COVID-19 …
respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical manifestations of COVID-19 …
[HTML][HTML] Short and long-term sequelae within the central nervous system due to COVID-19
LA Méndez-García, JD Carrillo-Ruiz… - Frontiers in Cellular …, 2023 - frontiersin.org
COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and has affected an estimated 664 million people with over 6.5 million deaths (Cumulative …
and has affected an estimated 664 million people with over 6.5 million deaths (Cumulative …
[HTML][HTML] Emerging COVID-19 neurological manifestations: present outlook and potential neurological challenges in COVID-19 pandemic
S Dewanjee, J Vallamkondu, RS Kalra… - Molecular …, 2021 - Springer
The unremitting coronavirus disease 2019 (COVID-19) pandemic caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase …
[HTML][HTML] Neuropathobiology of COVID-19: the role for glia
ME Tremblay, C Madore, M Bordeleau… - Frontiers in cellular …, 2020 - frontiersin.org
SARS-CoV-2, which causes the Coronavirus Disease 2019 (COVID-19) pandemic, has a
brain neurotropism through binding to the receptor angiotensin-converting enzyme 2 …
brain neurotropism through binding to the receptor angiotensin-converting enzyme 2 …
[HTML][HTML] Pathophysiological clues to how the emergent SARS-CoV-2 can potentially increase the susceptibility to neurodegeneration
Along with emergence of the novel severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) in late 2019, a myriad of neurologic symptoms, associated with structural brain …
CoV-2) in late 2019, a myriad of neurologic symptoms, associated with structural brain …
SARS-CoV-2 mediated neurological disorders in COVID-19: Measuring the pathophysiology and immune response
PC Hsu, M Shahed-Al-Mahmud - Life sciences, 2022 - Elsevier
The emergence of beta-coronavirus SARS-CoV-2 gets entry into its host cells by recognizing
angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 …
angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 …